Studies by Bowen and Blicher, on the other hand, observed significant or near significant decreases or decreases that approached significance in both Glx and NAA in ALS patients, which is not in line with the hypotheses outlined in section A Model for Changes in MRS Measured Glutamate, GABA, and Glutamine Levels During the Progression of ALS.
← all excerpts
<sup>1</sup>H Magnetic Resonance Spectroscopy to Understand the Biological Basis of ALS, Diagnose Patients Earlier, and Monitor Disease Progression.
1
—
—